炎琥宁注射液辅助治疗社区小儿上呼吸道感染疗效分析

Analysis of the Curative Effect of Potassium Sodium Dehydroandroandrographolide Succinate Injection Auxiliary Therapeutic Community of Upper Respiratory Tract Infection in Children

目的:探讨炎琥宁注射液辅助治疗社区小儿上呼吸道感染的临床疗效。方法:选取2012年3月-2014年9月笔者所在医院收治的90例社区上呼吸道感染患儿作为研究对象,采用随机数字表法将所选患者分为研究组和对照组,各45例。研究组在常规治疗基础上使用炎琥宁注射液辅助治疗,对照组使用利巴韦林注射液治疗,综合比较两组治疗总有效率和不良反应发生情况。结果:研究组治疗总有效率为97.8%,高于对照组的82.2%(P<0.05),研究组不良反应发生率为4.4%,低于对照组的17.8%(P<0.05)。结论:炎琥宁注射液辅助治疗社区小儿上呼吸道感染效果确切,不良反应少,安全可靠,值得临床推广使用。

Objective： To investigate the clinical efficacy of Potassium Sodium Dehydroandroandrographolide Succinate Injection adjuvant therapy in children with community of upper respiratory tract infection.Method： 90 cases of community children with upper respiratory tract infection were selected as the objects in our hospital from March 2012 to September 2014.They were randomly selected and divided into the study group and the control group, 45 eases in each group.The study group was treated with Potassium Sodium Dehydroandroandrographolide Succinate Injection adjuvant therapy on the basis of conventional therapy, while the control group was given Ribavirin Injection.The total treatment efficiency and adverse reaction incidence of two groups were comprehensivly compared. Result： The total effective rate of the study group was 97.8%, which was higher than 82.2% of the control group（P〈0.05）, the treatment adverse reaction rate of the study group was 4.4%, which was lower than 17.8% of the control group（P〈0.05）.Condusion： Potassium Sodium Dehyd Injection auxiliary therapeutic community in children with upper respiratory tract infection effect, has less adverse reaction, clinical use. Succinate safe and reliable, it is worthy of clinical use.